Humpath.com - Human pathology

A. Molecular pathology
B. Cellular pathology
C. Tissular pathology
D. Systemic pathology
E. Pathology by systems
F. Pathology by regions
G. Tumoral pathology
H. Case records
J. Books
K. Info - Admin
Resources in pathology
Technical section

Home > D. Systemic pathology > Toxics and drugs > Therapeutics > Targeted therapy > Small molecules > regorafenib

regorafenib

Monday 5 March 2012

The small molecule regorafenib is an anti-VEGFR.

D. Systemic pathology

Immune system diseases
Aging
Endocrine systemic anomalies
Environmental and occupational diseases
Genetic and developmental anomalies
Hematopathology
Infectious diseases
Nutritional diseases
Toxics and drugs
- Therapeutics
  - Targeted therapy
  - Gene therapy
Vascular anomalies

Search:

Also in this section

ganetespib
vismodegib
ponatinib
rucaparib
saridegib
regorafenib
axitinib
XL647-A
crizotinib
vemurafenib

1996-2013 Humpath.com - Human pathology
Site Map | Log in | Contact | RSS 2.0

SPIP